This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Focal adhesion kinase
From Proteopedia
(Difference between revisions)
| Line 12: | Line 12: | ||
FAK ATP-binding site is the <scene name='48/480805/Cv/5'>location of inhibitor binding</scene><ref>PMID:19030106</ref>. | FAK ATP-binding site is the <scene name='48/480805/Cv/5'>location of inhibitor binding</scene><ref>PMID:19030106</ref>. | ||
| + | == 3D Structures of focal adhesion kinase == | ||
| + | [[Focal adhesion kinase 3D structures]] | ||
</StructureSection> | </StructureSection> | ||
| Line 24: | Line 26: | ||
**[[1k04]], [[1k05]], [[3s9o]], [[2l6h]], [[2l6g]], [[2l6f]] – hFAK1 – human<br /> | **[[1k04]], [[1k05]], [[3s9o]], [[2l6h]], [[2l6g]], [[2l6f]] – hFAK1 – human<br /> | ||
| - | **[[1k40]] – mFAK1 – mouse<br /> | ||
| - | **[[5f28]] – mFAK1 + MEF2C<br /> | ||
**[[1ow6]], [[1ow7]] - hFAK1 + paxillin LD4 motif<br /> | **[[1ow6]], [[1ow7]] - hFAK1 + paxillin LD4 motif<br /> | ||
**[[1ow8]] - hFAK1 + paxillin LD2 motif<br /> | **[[1ow8]] - hFAK1 + paxillin LD2 motif<br /> | ||
**[[3b71]] - hFAK1 + ADP + ATP<BR /> | **[[3b71]] - hFAK1 + ADP + ATP<BR /> | ||
| + | **[[1k40]] – mFAK1 – mouse<br /> | ||
| + | **[[5f28]] – mFAK1 + MEF2C<br /> | ||
**[[1ktm]], [[1qvx]], [[1pv3]] - cFAK1 – chicken – NMR | **[[1ktm]], [[1qvx]], [[1pv3]] - cFAK1 – chicken – NMR | ||
| Line 34: | Line 36: | ||
**[[1mp8]] - hFAK1 <br /> | **[[1mp8]] - hFAK1 <br /> | ||
| - | **[[2etm]], [[3bz3]], [[4gu9]], [[4kab]], [[4k9y]], [[4i4e]], [[4i4f]], [[4k8a]], [[4gu6]], [[4brx]], [[4ebv]], [[4ebw]], [[3pxk]], [[4q9s]] - hFAK1 + inhibitor<br /> | + | **[[2etm]], [[3bz3]], [[4gu9]], [[4kab]], [[4k9y]], [[4i4e]], [[4i4f]], [[4k8a]], [[4gu6]], [[4brx]], [[4ebv]], [[4ebw]], [[3pxk]], [[4q9s]], [[6i8z]] - hFAK1 + inhibitor<br /> |
**[[4kao]] - hFAK1 (mutant) + pyrazole derivative<br /> | **[[4kao]] - hFAK1 (mutant) + pyrazole derivative<br /> | ||
**[[2ijm]] - hFAK1 + ADP + ATP<BR /> | **[[2ijm]] - hFAK1 + ADP + ATP<BR /> | ||
| Line 40: | Line 42: | ||
**[[2j0l]] - cFAK1 phosphorylated<br /> | **[[2j0l]] - cFAK1 phosphorylated<br /> | ||
**[[2jkk]], [[2jkm]], [[2jko]], [[2jkq]], [[4d58]] - cFAK1 + pyrimidine derivative<br /> | **[[2jkk]], [[2jkm]], [[2jko]], [[2jkq]], [[4d58]] - cFAK1 + pyrimidine derivative<br /> | ||
| - | **[[4c7t]] - cFAK1 + inhibitor<br /> | + | **[[4c7t]], [[6gcr]], [[6gcw]], [[6gcx]] - cFAK1 + inhibitor<br /> |
*''FAK1 FERM domain'' | *''FAK1 FERM domain'' | ||
| - | **[[2j0j]], [[2j0k]], [[2j0m]] - cFAK1 kinase + FERM domains<br /> | ||
| - | **[[2aeh]], [[2al6]] - cFAK1<br /> | ||
| - | **[[3zdt]] - cFAK1 (mutant)<br /> | ||
**[[4cye]] - hFAK1<br /> | **[[4cye]] - hFAK1<br /> | ||
**[[4ny0]] - hFAK1 (mutant)<br /> | **[[4ny0]] - hFAK1 (mutant)<br /> | ||
| + | **[[2j0j]], [[2j0k]], [[2j0m]] - cFAK1 kinase + FERM domains<br /> | ||
| + | **[[2aeh]], [[2al6]], [[6cb0]] - cFAK1<br /> | ||
| + | **[[3zdt]] - cFAK1 (mutant)<br /> | ||
*''FAK1 FAT domain'' | *''FAK1 FAT domain'' | ||
Revision as of 08:41, 3 July 2019
| |||||||||||
3D Structures of focal adhesion kinase
Updated on 03-July-2019
References
- ↑ Mitra SK, Hanson DA, Schlaepfer DD. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol. 2005 Jan;6(1):56-68. PMID:15688067 doi:http://dx.doi.org/10.1038/nrm1549
- ↑ Cabrita MA, Jones LM, Quizi JL, Sabourin LA, McKay BC, Addison CL. Focal adhesion kinase inhibitors are potent anti-angiogenic agents. Mol Oncol. 2011 Dec;5(6):517-26. doi: 10.1016/j.molonc.2011.10.004. Epub 2011 Oct, 20. PMID:22075057 doi:http://dx.doi.org/10.1016/j.molonc.2011.10.004
- ↑ Lietha D, Eck MJ. Crystal structures of the FAK kinase in complex with TAE226 and related bis-anilino pyrimidine inhibitors reveal a helical DFG conformation. PLoS ONE. 2008;3(11):e3800. Epub 2008 Nov 24. PMID:19030106 doi:10.1371/journal.pone.0003800
